5,369
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Advancing drug discovery via GPU-based deep learning

, , & ORCID Icon
Pages 579-582 | Received 13 Feb 2018, Accepted 12 Apr 2018, Published online: 18 Apr 2018

Figures & data

Table 1. A comparison of technical aspects of two recent GPU and CPU implementations.

Figure 1. Comparison of ANN compute times using CPU and CPU+GPU hardware. Hardware used: (Desktop) Dual 2.66 GHz 6-core Intel Xeon X5650 processors; (Server) Four 2.3 GHz 16-core AMD Opteron 6376 processors; (GPU1) Dual 2.4 GHz Intel Xeon E5-2620 processors and an ASUS GeForce GTX1080 STRIX graphics card; (GPU2) Four 3.6 GHz Intel Core i7 6850K processors and an ASUS GeForce GTX1080Ti STRIX graphics card.

Figure 1. Comparison of ANN compute times using CPU and CPU+GPU hardware. Hardware used: (Desktop) Dual 2.66 GHz 6-core Intel Xeon X5650 processors; (Server) Four 2.3 GHz 16-core AMD Opteron 6376 processors; (GPU1) Dual 2.4 GHz Intel Xeon E5-2620 processors and an ASUS GeForce GTX1080 STRIX graphics card; (GPU2) Four 3.6 GHz Intel Core i7 6850K processors and an ASUS GeForce GTX1080Ti STRIX graphics card.

Table 2. Directions and possibilities in DNN-based drug discovery.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.